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At birth, the heart undergoes a critical meta-
bolic switch from a predominant dependence
on carbohydrates during fetal life to a greater
dependence on postnatal oxidative metabo-
lism. This remains the principle metabolic state
throughout life, although pathologic conditions
such as heart failure and cardiac hypertrophy
reactivate components of the fetal genetic pro-
gram to increase carbohydrate utilization.
Disruption of the ERRg gene (Esrrg), which is
expressed at high levels in the fetal and postna-
tal mouse heart, blocks this switch, resulting in
lactatemia, electrocardiographic abnormalities,
and death during the first week of life. Genomic
ChIP-on-chip and expression analysis iden-
tifies ERRg as both a direct and an indirect reg-
ulator of a nuclear-encoded mitochondrial
genetic network that coordinates the postnatal
metabolic transition. These findings reveal an
unexpected and essential molecular genetic
component of the oxidative metabolic gene
program in the heart and highlight ERRg in the
study of cardiac hypertrophy and failure.
INTRODUCTION
The high energy demands of the heart are unrelenting and
must be tightly coordinated with energy production
throughout development and postnatal life. Depending
on the context, heart muscle principally consumes either
carbohydrate or lipid. Although the fetal heart consumes
predominantly carbohydrates, it undergoes an essential
postnatal shift to a mitochondrial program enabling more
than 70% of its energy demands to be achieved via fattyacid oxidation (Lehman and Kelly, 2002). While this switch
in energy substrate predisposition is a hallmark of the fe-
tal-to-adult transition, little is known about the molecular
genetics that direct this process (Bartelds et al., 2000). Im-
portantly, common features of animal models of hypertro-
phy or failure are altered substrate preferences, a reversion
to components of the fetal gene program, and increased
carbohydrate substrate preference in late stages (Lopa-
schuk, 2006). Transcriptional regulation of metabolic func-
tion has been shown to be highly dependent on the nuclear
receptor superfamily of transcription factors (Mangelsdorf
et al., 1995). Several nuclear receptors and their coactiva-
tor partners have been identified in the perinatal heart
(Sucov et al., 1994; Mangelsdorf et al., 1995; Barak et al.,
1999, Huss et al., 2002; Bookout et al., 2006); however,
their coordinated, hierarchical actions during substrate
switching in heart remain to be elucidated.
Nuclear receptors are divided into two groups: ligand-
dependent and ligand-independent (or orphan). Ligand-
dependent receptors, such as thyroid receptor (TR) and
the peroxisome proliferator-activated receptors (PPARs),
have been shown to have dramatic metabolic and func-
tional consequences in the heart. Indeed, a substantial
literature has focused on the role of thyroid hormone
signaling in both myocardial maturation and growth. In
addition, a critical coregulator of nuclear receptor func-
tion, PGC-1a, is highly expressed in the adult heart, where
it helps to maintain oxidative metabolism (Arany et al.,
2005, 2006). However, PGC-1a has pleiotropic transcrip-
tional targets and is known to be a dynamic mediator of
environmental and cell signaling cascades. Thus, the
extent to which ligand-independent orphan nuclear re-
ceptors, such as the estrogen-related receptors (ERRs),
contribute to PGC-1a-dependent mitochondrial and met-
abolic actions is unknown.
While heart was the initial cloning source of ERRa and
b (the first orphan nuclear receptors to be identified), their
roles in cardiac physiology and the fetal-to-adult transition
in particular remain unclear (Gigue`re et al., 1988).Cell Metabolism 6, 13–24, July 2007 ª2007 Elsevier Inc. 13
Cell Metabolism
Conduction and Metabolic Defects in ERRg Null MiceNevertheless, ERRa has been shown to regulate the
expression of several mitochondrial genes in vitro,
strengthening its likely role in cardiac physiology. Al-
though ERRa null mice are viable (Luo et al., 2003), the
presence of ERRa has recently been shown to be essen-
tial for the adaptive bioenergetic response to hemody-
namic stressors known to cause heart failure (Huss
et al., 2007 [this issue of Cell Metabolism]). ERRb null
mice are midgestationally lethal due to placental defects,
leaving ERRb’s contribution to heart function unresolved
(Gigue`re et al., 1988; Luo et al., 1997). The close relation-
ships between ERRg and ERRa in DNA motif recognition
and coactivator interaction suggested that ERRg might
functionally mimic ERRa in mitochondrial function and
biogenesis in heart (Willy et al., 2004; Schreiber et al.,
2003; Huss and Kelly, 2004; Dufour et al., 2007). Although
the role of ERRg is not known, its abundant expression
in the developing and adult heart, combined with the re-
cent demonstration that ERRa and g target a common
set of promoters in the adult heart (Dufour et al., 2007),
suggests a probable role in metabolic function.
In the present study, we generated mice lacking ERRg,
the last ERR to be characterized in vivo. ERRg null mice
die during the first week of life due to abnormal heart
and spinal cord function. Genomic analysis reveals that
ERRg regulates a network of nuclear-encoded mitochon-
drial genes that control oxidative metabolic function. In
the E18.5 heart, Esrrg/ mice have alterations in electro-
cardiograms, metabolic gene expression, and mitochon-
drial function and fail to switch to an oxidative gene
program during the perinatal period. These findings reveal
a critical role for ERRg in the control of metabolic switch-
ing, the hallmark of fetal-to-adult transition.
RESULTS
Generation of Esrrg/ Mice
To examine the functions of ERRg in vivo, we disrupted
the mouse Esrrg gene by homologous recombination in
embryonic stem (ES) cells and generated Esrrg mutant
mice. The targeted mutation deletes most of exon 2, which
encodes the DNA-binding domain (DBD), and introduces
a premature stop codon in the event of alternative splicing
(Figure 1A). The mutation also introduces a promoterless
b-galactosidase protein-coding region in frame with the
initiation codon of the Esrrg gene. Targeting of Esrrg in
ES cells was confirmed by Southern blot analysis and
genotyping performed by PCR (Figure 1B). RT-PCR anal-
ysis and immunohistochemistry of ERRg null mice re-
vealed an absence of both transcript and protein (data
not shown). Mice heterozygous for the Esrrg mutation
were viable, fertile, and phenotypically normal. Heterozy-
gote intercrosses in congenic C57BL/6, SV129, or ICR
backgrounds, as well as a SV129/C57BL/6 mixed back-
ground, failed to produce mutant adults. By timed mating
of heterozygous mutant mice, we determined that geno-
types of mice showed Mendelian ratios of inheritance up
to the day of birth (P0), but no homozygous mutants
were obtained beyond postnatal day 1 (P1) (data not14 Cell Metabolism 6, 13–24, July 2007 ª2007 Elsevier Inc.shown). ERRg null mice were grossly indistinguishable
from wild-type pups before P0. However, newborn P0
ERRg null mice had reduced body weight and displayed
fewer milk spots (Figure 1F; data not shown).
ERRg Is Highly Expressed in the Heart
To begin to determine the cause of lethality in ERRg mu-
tant mice, we analyzed ERRg expression by whole-mount
X-gal embryo staining. Strong expression of the LacZ
gene under the control of the Esrrg promoter was ob-
served in heart (arrows, Figure 1C) and throughout the
central nervous system (arrowheads, Figure 1C). Robust
expression was noted throughout the heart by E8.5 and
continued through development and postnatal life. This
expression was limited to the heart, was not observed in
the major vessels or lungs, and was confirmed by northern
blot and RT-PCR (data not shown; Bookout et al., 2006).
X-gal analysis at E18.5 revealed prominent ERRg reporter
expression in the ventricles (Figure 1D). ERRg null hearts
were smaller in cross-section; however, no other anatom-
ical differences, save size, were observed in ERRg mutant
hearts. Light microscopic and ultrastructural examination
of hearts at E18.5 demonstrated normal myofibrillar archi-
tecture and normal mitochondrial architecture, size, and
number (Figure 1E).
Because Esrrg/ mice do not compete well with wild-
type littermates for feeding under standard conditions,
we evaluated mice delivered by caesarean section (C
section) at E18.5 and examined for 24 hr. Under these
conditions, Esrrg/ mice had a normal body mass (Fig-
ure 1F) and blood values for glucose and lactate (see be-
low), which allowed well-controlled examination of ERRg
null mice. Interestingly, E18.5 Esrrg+/ and Esrrg/ mice
showed reduction in ventricular mass by 7% and 9%,
respectively, prompting an analysis of heart rate, rhythm,
and conduction (Figure 1G).
ERRg Maintains Cardiac Conduction Integrity
An electrocardiogram (ECG) system employing miniatur-
ized leads was developed to monitor heart rate, rhythm,
and conduction. Electrodes were attached in a lead II
arrangement, and signals were digitized, stored, and ana-
lyzed by a semiautomated PC-based system. Control
ECG traces are shown in black in Figure 2A, and ERRg
nulls are shown in red. At E18.5, ECG analysis revealed
two key electrophysiologic abnormalities in ex utero c
section-delivered mice. First, while heart rate and PR in-
tervals indicated normal nodal and atrial function, the de-
polarization of the ventricle was highly abnormal. The QRS
complex, which reflects the depolarization of the ventricle,
was prolonged by 30% in the ERRg null mice (Figure 2A,
upper panel; Table 1) and 13% in ERRg heterozygous
mice (Table 1). Twenty-four hours later, the QRS complex
was increased by 44% in the P0 null animals (Figure 2A,
lower panel; Table 1). The morphologies of the ECG traces
were also abnormal in the mutant animals at E18.5, with
notching or fractionation of the QRS complex, indicative
of left or right bundle branch block (BBB). Left or right
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Conduction and Metabolic Defects in ERRg Null MiceFigure 1. ERRg Is Highly Expressed in the Developing Heart
(A) Targeted homologous recombination was achieved by insertion of
a b-galactosidase/neomycin fusion cassette into the second exon of
Esrrg in mouse ES cells. The resulting locus produces a b-galactosi-
dase reporter but does not produce ERRg transcript or protein due
to the production of premature stop codons.
(B) PCR genotyping of offspring from Esrrg+/ hybrid crosses pro-
duces predicted amplicons of 301 bp for the null allele and 486 bp
for the wild-type allele in this inverted ethidium bromide-stained ultra-
violet exposure.
(C) X-gal staining indicates that ERRg is highly expressed throughout
the developing heart (arrows) and spinal cord (arrowheads) at embry-
onic days (E) 8.5, 10.5, and 13.5. X-gal staining was not observed in the
vessels or lungs.BBB was seen in 70% of the null and 27% of the hetero-
zygous animals (Figure 2B).
Second, ERRg null mice showed a striking increase in
the durations of the ST, QT, and QTc intervals, reflecting
a defect in the ability of the ventricular cardiomyocytes
to repolarize (Figure 2A; Table 1). The substantial 10% in-
crease in the QT interval at E18.5 and massive 51% in-
crease at P0 is a predisposing factor in sudden cardiac
death in mice (Chien, 2004). No sudden cardiac deaths
were recorded by ECG in the ERRg null mice, which
died within 48 hr of birth.
Sodium Current in ERRg Null Ventricular
Cardiomyocytes
The broadened QRS interval in ERRg mutant mice is due
to slowed conduction in the ventricles. Sodium current
was examined because it underlies the ventricular action
potential and conduction velocity and the depolarization
of the QRS complex (Nerbonne and Kass, 2005; Chien,
2004; Marban, 2002; Katz, 2001). Patch-clamp experi-
ments in E18.5 primary ventricular myocytes were used
to examine the voltage-dependent sodium current (Exper-
imental Procedures; Nuss and Marban, 1994; Brouillette
et al., 2003). A robust reduction in the sodium current den-
sity in cardiac myocytes from Esrrg/ mice compared to
wild-type controls was recorded (at 30 mV, in pA/pF ±
SEM: wild-type, 134.5 ± 19; Esrrg/, 82 ± 14.2; p <
0.03; Figure 2C). Furthermore, a corresponding reduction
in message for the major sodium channel, Scn5a, and its
subunit, Scn1b, was measured in a qPCR panel of chan-
nels (Figure 2E; Gavillet et al., 2006). While there was
a 2-fold increase in the message for Scn1a in the ERRg
null hearts, this did not appear to substantially alter either
the voltage-dependent activation or inactivation of the so-
dium current because of the relatively small contribution of
this neuronal channel to cardiac sodium current
(Figure 2D). The similar voltage-dependent activation
and inactivation records indicated that ERRg null myo-
cytes have a comparable profile of sodium channel types
(D) X-gal staining of E18.5 heart demonstrates robust staining in
ventricles. The reduced cross-sectional dimensions of the ERRg null
and heterozygous midventricle sections relative to wild-type littermate
controls are reflected in reduced ventricular mass (see below).
(E) Light and electron microscopy did not detect significant derange-
ment of myofibers by hematoxylin and eosin (H&E) staining. Masson’s
trichrome did not detect fibrosis in ERRg null mice. Electron micro-
scopic (EM) analysis of ultrastructure did not detect substantial myofi-
brillar or mitochondrial differences in E18.5 ERRg null mice relative to
wild-type littermate controls.
(F) ERRg null mice had normal body weights at E18.5, but at day of
birth (P0) and postnatal day 1 (P1), body weight was significantly lower
in ERRg null mice than wild-type littermate controls (p < 0.001; n =
860). ERRg null mice were generated at a Mendelian frequency at
E18.5 and P0, but no ERRg null mice were recovered after the first
48 postnatal hr (p < 0.001; n = 1185). In this and all other figures, error
bars represent SEM unless stated otherwise; *p < 0.05; ***p < 0.001.
(G) ERRg null and heterozygous mice had significantly reduced
indexed ventricular mass at E18.5 despite having normal body mass
relative to wild-type littermate controls (p < 0.001; n = 232).Cell Metabolism 6, 13–24, July 2007 ª2007 Elsevier Inc. 15
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(A) Caesarean section (c section)-delivered E18.5 ERRg null and heterozygous mice had widened QRS complexes, and ERRg null mice had
prolonged ST and QT intervals (p < 0.001; Table 1). Over P0, the QRS, ST, and QT intervals became further abnormal in ERRg null mice
(p < 0.001; Table 1).
(B) Bundle branch block (BBB) due to slowed conduction in the ventricles produces characteristic trace morphology in the ECG recordings; the
numbers of the abnormal morphologies were quantified. Loss of ERRg in E18.5 mice produced an increase in abnormal ECG morphologies in
both heterozygous and knockout animals (p < 0.001; n = 90).
(C) Patch-clamp experiments in E18.5 primary ventricular cardiomyocytes demonstrated dramatically reduced voltage-gated sodium current in ERRg
null ventricular myocytes relative to wild-type controls. The voltage-gated sodium current determines the rate of depolarization and underlies the
slowed ventricular conduction.
(D) Normalized peak sodium conductance was indistinguishable between ERRg null and wild-type cells during voltage-dependent activation or
inactivation and suggested a similar population, although with a reduced number of channels.
(E) Quantitative PCR revealed a significant reduction in message for the predominant sodium channel, Scn5a, and its subunit, Scn1b (p < 0.05; n = 6).
Additionally, neuronal sodium channelScn1amRNA inEsrrg/ myocardium is inappropriately overexpressed (p < 0.05; n = 6). In this panel, error bars
represent SD.relative to wild-type but that they are reduced in number or
have reduced unitary conductance (Figure 2C).
Esrrg/ Mice Have Fasting Lactatemia
In addition to these electrophysiologic measures, and to
examine ERRg as a key regulator of metabolic function,
we examined the blood of neonatal mice for lactate, often
the first clinical sign of metabolic disturbances. Clinically,
the appreciation of mitochondrial dysfunction can be re-
vealed by a physiologic challenge such as trauma, illness,
or fasting that produces increased levels of lactate (Smei-
tink et al., 2006). After a fast of 4 hr in c-sectioned mice,
blood lactate was indistinguishable in all mice (Figure 3A).16 Cell Metabolism 6, 13–24, July 2007 ª2007 Elsevier Inc.Because lactate levels were normal at 4 hr, this excluded
alternative causes of lactic acidosis that could be impor-
tant in ERRg mutant mice, such as defective perfusion
due to severely abnormal heart function or defective
vasculogenesis. However, after 8 and 12 hr of fasting, lac-
tate levels in the ERRg null mice were elevated by 50%
above wild-type and heterozygous controls (Figure 3A).
Importantly, despite this metabolic derangement, all fast-
ing c-sectioned E18.5 mice maintained normal blood
glucose levels, regardless of genotype, at 4 hr, 8 hr, and
12 hr (Figure 3B). The production of lactate, likely due to
the failure of Esrrg/ mice to metabolize pyruvate via
the citric acid cycle within mitochondria, resembles
Cell Metabolism
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E18.5 (n = 220) RR P PR QRS ST QT QTc
Esrrg+/+ 159.1 ± 2.6 12.5 ± 0.4 56.9 ± 1.1 9.1 ± 0.2 70.6 ± 1.2 79.7 ± 1.2 199.9 ± 2.2
Esrrg+/ 162.5 ± 2.0 12.8 ± 0.3 58.2 ± 0.7 10.2 ± 0.2 72.7 ± 1.0 82.9 ± 1.1 205.5 ± 1.9
Esrrg/ 164.3 ± 2.5 12.6 ± 0.3 56.4 ± 0.9 11.8 ± 0.2 76.8 ± 1.3 87.9 ± 1.3 216.8 ± 2.1
p (+/+ versus /) NS NS NS <0.001 <0.001 <0.001 <0.001
p (+/+ versus +/) NS NS NS <0.001 NS NS NS
P0 (n = 90) RR P PR QRS ST QT QTc
Esrrg+/+ 149.0 ± 3.8 11.4 ± 0.7 52.4 ± 1.5 8.2 ± 0.3 60.1 ± 1.9 68.4 ± 2.0 176.7 ± 0.5
Esrrg+/ 153.4 ± 3.3 12.8 ± 0.4 55.4 ± 1.6 8.9 ± 0.3 62.9 ± 1.5 71.8 ± 1.7 182.9 ± 2.9
Esrrg/ 229.1 ± 9.7 13.9 ± 0.7 72.0 ± 2.2 11.8 ± 0.6 91.2 ± 2.2 103.0 ± 2.3 216.7 ± 3.7
p (+/+ versus /) <0.001 <0.05 <0.001 <0.001 <0.001 <0.001 <0.001
p (+/+ versus +/) NS NS NS NS NS NS NS
Loss of ERRg results in significantly longer QRS durations in heterozygous and null c section-delivered E18.5 mice. Both QT
and QTc intervals are increased in null mice. By postnatal day 0, all ECG parameters are significantly altered in ERRg null mice,
while heterozygous mice are not significantly different from wild type. RR, P, PR, QRS, ST, and QT values are given in mean
milliseconds ± SEM. NS, not significant.defects seen in complex I and IV deficiencies that often
include cardiac myopathies and arrhythmias (Gilbert-Bar-
ness, 2004; DiMauro et al., 1990; DiMauro, 1993).
ERRg Regulates Mitochondrial Genome Number
Having demonstrated a mitochondrial defect at the level
of the whole animal, we sought a marker of mitochondrial
dysfunction at the level of the organelle. The circular mito-
chondrial genome (mtDNA) copy number can vary inde-
pendently of the nuclear genome or mitochondrial number
and serves as a key marker of physiological stress or
genetic mutations (Nouette-Gaulain et al., 2005). Exami-
nation of genomic DNA from E18.5 cardiac ventricle or
10 mg of liver was performed by quantitative PCR prob-
ing the 18S ribosomal gene (nuclear genome, nDNA) and
the cytochrome b gene (mtDNA). The ratio of mtDNA to
nDNA in wild-type heart was arbitrarily set to 1. In heart,
the mtDNA:nDNA ratio was massively increased by
58% in Esrrg+/ mice (p < 0.05) and 90% in Esrrg/
mice (p < 0.001; Figure 3C). Because ERRg is not sub-
stantially expressed in the liver (by northern blot, LacZ
expression, or qPCR), this tissue serves as a control
where no change in ratio was observed (Figure 3D; Book-
out et al., 2006).
ERRg Null Hearts Have Altered Electron Transport
Chain Biochemical Activities
The mitochondrial genome encodes 13 proteins that act
inconcertwith nuclear-encoded genes to composethe mul-
tiprotein (100) complexes of the electron transport chain.
Because loss of ERRg increased the mtDNA:nDNA ratio,
wenext examined the biochemical functionof mitochondrial
matrix enzymes and electron transport chain (ETC) enzyme
complexes. Despite the increase in mtDNA:nDNA, analysis
ofE18.5 ventricle revealed thatcitrate synthase (CS)specific
activity was dramatically reduced by approximately 26%in ERRg null animals relative to wild-type (Figure 3E). In con-
trast, complex IV activity was substantially increased by
53% in the Esrrg/ animals relative to wild-type when nor-
malized to CS (Figure 3F). Complex I activity was lower in
proportion to total protein (Figure 3G) but was proportional
to CS activity (Figure 3H). The upregulation of the
mtDNA:nDNA ratio fails to compensate for the presumed
deficiency of critical ERRg target gene products needed
for normal ETC function.
ERRg Selectively Regulates Key Mitochondrial
Genes
To determine the genetic basis for the altered mitochon-
drial function observed, a DNA microarray analysis was
performed to detect ERRg-dependent changes in gene
expression. The changes in electrophysiologic, molecular,
and enzymatic activities in the ventricle led us to examine
this tissue from wild-type, Esrrg+/, and Esrrg/ E18.5
male mice. Collectively, heterozygous mice showed
2754 gene expression changes and ERRg nulls showed
3725, with an approximately 70% overlap between the
two sets (Figure 4A). Since ERRg is considered to be con-
stitutively active (as are ERRa and b) (Xie et al., 1999), we
expected Esrrg+/ and Esrrg/ mice to show a net de-
crease in gene expression. In ERRg null mice, this com-
parison revealed that 1666 genes were reduced (Esrrg in-
cluded) while 2059 were upregulated relative to wild-type
controls, a probable indication of the many indirect effects
of the knockout (see Figure 4A and below).
As a second measure of direct ERRg target genes,
chromatin immunoprecipitation (ChIP) was used to inter-
rogate a microarray chip containing 18,657 1 kb pro-
moters (800 to +200 from the transcription start site;
ChIP-on-chip; Experimental Procedures). ChIP-on-chip
experiments were performed on neonatal heart tissues
and, where relevant, were compared to a recentCell Metabolism 6, 13–24, July 2007 ª2007 Elsevier Inc. 17
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Defects
(A) Fasting lactate levels were normal in c-sectioned E18.5 ERRg null
mice at 4 hr but underwent a significant 50% increase above wild-
type littermate controls by 8 and 12 hr (p < 0.001; n R 16 at all time
points).
(B) Loss of ERRg did not alter the ability of fasting c-sectioned E18.5
mice to maintain blood glucose levels at 4, 8, or 12 hr (n R 16 at all
time points).
(C) Mitochondria have multiple circular genomes (mtDNA) that are rep-
licated independently from the nuclear genome (nDNA). Loss of ERRg
resulted in an approximately 50% increase in mtDNA in heterozygous
E18.5 hearts and an approximately 90% increase in ERRg null hearts
(p < 0.001, n = 12).
(D) ERRg is not highly expressed in liver, and mitochondrial DNA is not
altered by loss of ERRg in this tissue.
(E) Electron transport chain (ETC) biochemical analysis reveals that
E18.5 ERRg null mice have significantly reduced citrate synthase
(CS) activity, a clinical marker of mitochondrial mass (p < 0.001; n = 10).
(F) Complex IV (cytochrome c oxidase) of the mitochondrial ETC in
E18.5 ERRg null cardiac ventricle had reduced enzymatic activity
when normalized to CS activity (p < 0.001; n = 10).
(G) Complex I (NADH dehydrogenase) of the mitochondrial ETC in
E18.5 ERRg null cardiac ventricle had reduced enzymatic activity
when normalized to total protein (p < 0.001; n = 10).18 Cell Metabolism 6, 13–24, July 2007 ª2007 Elsevier Inc.companion adult heart ChIP-on-chip study (Dufour et al.,
2007). Within the expression array results, several direct
targets were identified by ChIP-on-chip and confirmed
by conventional ChIP (Figure 4B).
Because ERRa and g can activate common target
genes via association with key cofactors, we investigated
the possibility of compensatory induction by components
of the signaling cascade. Indeed, in both Esrrg/ and, to
a lesser extent, Esrrg+/ mice, PGC-1a, Foxo1, ERRa and
b, and Gabpa (nuclear respiratory factor 2; Esrrg/ only)
were all detected as upregulated, while PPARd and
PPARg were downregulated (Figure 4C; see also Table
S1 in the Supplemental Data available with this article
online; Barry et al., 2006; Zhang et al., 2006, Kamei
et al., 2003, Laganiere et al., 2004; Mootha et al., 2004;
Schreiber et al., 2003).
In addition, message for a variety of muscle-associated
transcription factors such as Mef2a, Mef2c, and Nurr77
was also upregulated in the dramatically smaller Esrrg/
and Esrrg+/ ventricles (Figure 4C; Table S1; Lin et al.,
1997; Maxwell and Muscat, 2006). Broad classes of down-
stream target genes associated with muscle and cardiac
disorders (e.g., Lmod2, Lmod3, Myh9, Ttn, Tnnt1, Foxk1,
and Tpm3) were upregulated or downregulated in both
Esrrg+/ and Esrrg/ hearts relative to wild-type controls
(Figure 4C; Table 2; Table S1; Lin et al., 1997; MacLellan
et al., 2000; Stennard et al., 2005; Maxwell and Muscat,
2006).
In addition to altering transcription factors associated
with metabolic function (ERRa, ERRb, PPARg, PPARd,
Foxo1, and Gabpa), ERRg deletion resulted in the dysre-
gulation of several components of the mitochondrial
oxidative phosphorylation (OXPHOS) pathway, including
at least 15 NADH dehydrogenase (ETC complex I) subunits
(Figure 4C; Table 2; Table S1). Interestingly, Ndufb5 and
Ndufs7 were detected by ChIP-on-chip in both neonatal
and adult hearts (Figure 4B; Dufour et al., 2007). Ndufb5
was upregulated approximately 50% in both Esrrg+/
andEsrrg/ hearts, suggesting compensation through in-
creased ERRa expression, which was also detected by
ChIP at this promoter (Dufour et al., 2007). In contrast,
Ndufs7 remained downregulated in Esrrg/ hearts, indi-
cating greater dependence upon ERRg (Figures 4B and
4C). Three cytochrome oxidases (Cox5a, 11, and 15)
were upregulated, while Cox4nb, 5b, 6b1, 8a, and 10
were downregulated (Figure 4C; Table S1). Combinatorial
control of cytochrome c (Cycs) and components of com-
plexes IV and V by ERRa and ERRg was indicated as
well (Figures 4B and 4C; Figure 5; Table S1; Mootha
et al., 2004; Schreiber et al., 2003; Dufour et al., 2007).
ChIP-on-chip for promoters of targets related to the
high-energy phosphate pool, Ckmt2 and Slc25a4/ANT1,
have detected ERRa and ERRg (Figures 4B and 4C; Table
2; Table S1; Dufour et al., 2007), whose expression was
(H) Complex IV (cytochrome c oxidase) of the mitochondrial ETC in
E18.5 ERRg null cardiac ventricle had normal enzymatic activity
when normalized to total protein, indicating a derangement in stoichi-
ometries for the ETC complexes (p < 0.001; n = 10).
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Reveals Target Gene Candidates
(A) Venn diagram representations of genes up-
regulated (red) and downregulated (green) in
microarray expression analysis of E18.5
ERRg heterozygous and null cardiac ventricle.
A greater number of genes were detected as
upregulated despite the loss of the constitu-
tively active transcription factor ERRg, sug-
gesting broad compensatory homeostatic
mechanisms.
(B) Conventional chromatin immunoprecipita-
tion (ChIP) of promoter regions from neonatal
heart confirmed direct regulation of several
ERRg targets involved in metabolic and con-
tractile function that were originally detected
by ChIP-on-chip (see Results).
(C) Heat-map representations of several key
classes of genes detected in expression analy-
sis of ERRg null heart. Contractile genes in-
clude sarcolemmal and anchoring genes.
ETC/OXPHOS includes genes involved in
high-energy phosphate metabolism.also changed in ERRa null hearts (Table 2; Table S1; Huss
et al., 2007).
Disruption of the perinatal metabolic switching with loss
of ERRg is reflected in a large number of genes involved in
fatty acid oxidation (FAO) being downregulated in ERRg
null heart. Importantly, Acadm (first step in FAO), Acaa2
(last step in FAO), Cpt1b, Cpt2, Slc25a29, and Fabp3
are downregulated in hearts lacking ERRg (Figure 4C; Ta-
ble S1). Interestingly, expression ofAcc2 (which favors the
formation of malonyl-CoA, an inhibitor of FAO via Cpt1 in-
hibition), is downregulated as well. Furthermore, many of
the subunits of AMPK, which can phosphorylate and in-
hibit Acc2, are upregulated. Overall, expression changes
in these key genes reflect inappropriate metabolic switch-
ing to FAO in ERRg null hearts.
Because ERRg null mice develop lactatemia, we hy-
pothesized that these mice have defects in metabolic
fuel sensing and/or handling. In addition to those listed
above, transcripts for the key metabolic genes lactate de-
hydrogenase B (Ldhb), hexokinase 1 (Hk1), hexose-6-
phosphate dehydrogenase (H6pd), and palmitoylcarnitine
transporter (CACL, Slc25a29) were all downregulated inERRg null mice. Additionally, the pyruvate dehydrogenase
enzyme complex displayed reduced expression of sub-
unit Pdhx, while the pyruvate dehydrogenase kinase,
Pdk1, was upregulated (Figure 4C; Table S1). These
changes in gene expression are consistent with our ob-
served increase in cytosolic pyruvate, conversion of pyru-
vate to lactate, and subsequent lactatemia, phenomena
that are signature metabolic changes of cardiac hypertro-
phy and heart failure and may contribute to the lethality of
the phenotype (Figure 3A and Figure 5; Robinson, 2006;
Harris et al., 2002).
DISCUSSION
The heart, as a mechanical pump, develops early and
functions throughout fetal life using maternal glucose as
its principal nutrient. The transition to aerobic metabolism
at birth triggers a massive change in fuel substrates en-
gaging associated biochemical pathways for fatty acid
metabolism, the enzymes directing these reactions, and
the regulatory mechanisms that integrate this process
(Lehman and Kelly, 2002). Surprisingly little is knownCell Metabolism 6, 13–24, July 2007 ª2007 Elsevier Inc. 19
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Gene Symbol Fold p Reference
Actin Acta1 1.3 1.4 3 104 Hwang et al. (2000)
a-actinin Actn1 +1.2 1.0 3 103 Kostin et al. (2000)
AMPKg2 Prkag2 +1.4 3.1 3 105a Morita et al. (2005)
ATP/ADP translocator (Ant1) Slc25a4 +1.3 3.7 3 105 Hwang et al. (2000)
Calsequestrin Casq2 1.4 1.1 3 105 Postma et al. (2002)
CD59 antigen Cd59 +1.3 5.7 3 105 Hwang et al. (2000)
Creatine kinase, mitochondrial Ckmt2 2.2 2.1 3 1021 Hwang et al. (2000)
Cyclin A2 Ccna2 1.2 2.0 3 103 Woo et al. (2006)
Cytochrome p450 IVB1 Cyp4b1 +1.9 1.5 3 106a Thum and Borlak (2000)
Cytochrome c Cycs +1.2 2.0 3 103a Hwang et al. (2000)
Dystroglycan 1 Dag1 1.3 7.0 3 104a Morita et al. (2005)
Estrogen-related receptor a Esrra +1.2 4.8 3 103 Huss et al. (2007)
Ets1 oncogene Ets1 +1.3 1.3 3 108 Lie-Venema et al. (2003)
Fatty acid binding protein 3 Fabp3 1.2 3.0 3 103 Binas et al. (2003)
Gelsolin, plasma Gsn +1.6 8.6 3 1011a Hwang et al. (2000)
Glutathione peroxidase Gpx3 1.5 4.5 3 108 Hwang et al. (2000)
Glycogenin Gyg1 +1.3 2.6 3 104a Hwang et al. (2000)
Lysosome-associated membrane protein Lamp2 +2.9 1.6 3 1037a Morita et al. (2005)
LIM domain binding 3 Ldb3 1.4 4.5 3 107 Morita et al. (2005)
Long-chain acyl-CoA synthase Acsl1 1.3 1.0 3 104 Hwang et al. (2000)
Malate dehydrogenase 1 Mdh1 1.4 3.8 3 103 Lo et al. (2005)
Multiprotein bridging factor Edf1 1.3 6.6 3 104a Busk et al. (2003)
Myoglobin Mb 1.3 2.3 3 104 Hwang et al. (2000)
Myosin heavy chain 6 Myh6 +1.3 9.0 3 105a Niimura et al. (2002)
NADH dehydrogenase Fe-S 7 Ndufs7 1.3 3.1 3 104 Smeitink and van den Heuvel (1999)
NADH dehydrogenase Fe-S 8 Ndufs8 1.2 2.0 3 103 Smeitink and van den Heuvel (1999)
PCG-1a Ppargc1a +2.0 5.3 3 1014a Lehman et al. (2000)
Prostaglandin D synthase Ptgds 1.5 1.3 3 107 Hwang et al. (2000)
Pyruvate dehydrogenase kinase Pdk1 +1.5 3.6 3 108a Mora et al. (2003)
PDZ and LIM domain protein 3 Pdlim3 +1.8 4.3 3 1015a Pashmforoush et al. (2001)
Ran binding protein 2 Ranbp2 +1.5 1.5 3 10-6a Hwang et al. (2000)
Sarcoglycan b Sgcb +2.0 2.8 3 1016a Morita et al. (2005)
SC-35 Sfrs2 1.5 1.3 3 107 Ding et al. (2004)
Syntrophin b2 Sntb2 1.4 1.0 3 103a Morita et al. (2005)
Ribosomal protein S12 Rps12 +1.3 3.2 3 105a Hwang et al. (2000)
T-box 18 Tbx18 +1.9 1.9 3 1013a Christoffels et al. (2006)
T-box 20 Tbx20 +1.8 2.1 3 1015a Stennard et al. (2005)
Titin Ttn 1.3 2.0 3 104a LeWinter et al. (2007)
Trifunctional protein a Hadha 1.3 2.6 3 104 Brackett et al. (1995)
Tropomyosin, skeletal muscle a Tpm1 1.5 2.9 3 105 Hwang et al. (2000)
Troponin T Tnnt2 +1.3 8.1 3 105a Hwang et al. (2000)
Numerous genes detected as altered in ERRg null mice are associated with cardiac development and human cases or mouse models of
cardiac hypertrophy or failure.
a Detected in heterozygous versus wild-type.20 Cell Metabolism 6, 13–24, July 2007 ª2007 Elsevier Inc.
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expression from the knockout allele in fetal and postnatal
hearts suggests that the observed lactatemia, ECG abnor-
malities, and newborn mortality are due to ERRg defi-
ciency. Not only does the knockout disrupt metabolic con-
version, target gene analysis indicates that it plays a key
role in governing the transition. Combined with genomic
ChIP-on-chip data, ERRg is found here to be a principle
regulator of nuclear-encoded mitochondrial genes that
establish and most likely maintain the oxidative metabolic
gene program in the heart.
ERRg Maintains Electrophysiologic and Metabolic
Integrity
Despite the normal body weight (Figure 1F) and blood glu-
cose (Figure 3B) of ERRg null mice, several critical
changes at E18.5 are noteworthy. Although loss of robust
Figure 5. ERRg Directs and Maintains the Transition to
Oxidative Metabolism in the Postnatal Heart
(A) The orphan nuclear receptor ERRg controls the handling of lactate
and pyruvate during the fetal-to-adult transition that results in a switch
from carbohydrate-based to lipid-based oxidative metabolism.
(B) Several metabolic effects on mitochondrial function and cytosolic
substrate sensing and utilization were identified in ERRg null hearts.
ERRg null mice have smaller cardiac ventricles, altered contractile
apparatus gene expression, and prolonged QRS and QT intervals by
ECG. In addition, loss of ERRg produces abnormal fatty acid oxidation
(FAO) gene expression, increased mitochondrial DNA, and aberrations
in electron transport complex/OXPHOS gene expression and enzy-
matic activities. Furthermore, deranged gene expression in carbohy-
drate handling results in lactatemia.expression of ERRg in the heart results in a modest reduc-
tion in ventricular mass (Figure 1G), histological and ultra-
structural analysis revealed a substantially normal heart.
However, the ECG was strikingly abnormal, with both de-
polarization (indicated by broadened, fractionated QRS
complexes) and repolarization (indicated by prolonged
QT intervals) markedly skewed at E18.5 and P0. Impor-
tantly, ERRg null mice are unable to appropriately con-
sume pyruvate, resulting in lactatemia after c section
(Figure 3A), suggesting a defect in the neonatal metabolic
transition. Examination of mitochondrial functions in ERRg
null heart revealed reductions in citrate synthase needed
for pyruvate-derived acetyl-CoA entry to the tricarboxylic
acid cycle. In contrast, the wild-type postnatal heart read-
ily consumes both pyruvate and lactate as energy sources.
In addition, reduced complex I activity in ERRgmutants in-
creases the NADH/NAD+ ratio, reduces ETC flux, and in-
creases cytosolic pyruvate levels, favoring the formation
of lactate (Figures 3C–3G). Because of these interrelated
metabolic defects, ERRg null mice cannot effectively en-
gage oxidative metabolism and are unable to survive be-
yond P1 despite Mendelian ratios of offspring at P0.
A comparative genomic expression analysis of wild-
type and ERRg mutants identified changes in a large
cohort of genes involved in fatty acid oxidation, ETC and
mitochondrial matrix function, high-energy phosphate
handling, glycolysis, and transcriptional regulation (Fig-
ure 5B). Furthermore, at least ten NADH dehydrogenase
(ETC/complex I) subunits were downregulated (Figure 4C).
Interestingly, mitochondrial DNA content was increased
nearly 2-fold in ERRg null mice, possibly as an attempt
to compensate for the numerous dysregulated metabolic
genes. Consistent with this idea, several transcriptional
regulators of mitochondrial function were upregulated
(e.g., PGC-1a, ERRa, and NRF-2). Additionally, we ob-
served broad dysregulation of various myogenic and
contractile genes in the ERRg null hearts that appeared
to contribute to their reduced mass (Figures 1D and 1G;
Figures 4B and 4C; Figure 5B).
Genome-wide ChIP studies have indicated that numer-
ous metabolic, mitochondrial, and contractile genes have
promoters occupied by ERRa and g in the adult heart
(Dufour et al., 2007). ChIP-on-chip studies performed on
neonatal heart in this report (Figure 4; Table S1) further
demonstrate that many of the above changes are a conse-
quence of direct binding of ERRg to key target genes. It
would appear from the aggregate consequences of these
changes that ERRg plays a key role in transitioning from
carbohydrate-based to lipid-based metabolism. Other
processes in mitochondrial function and regulation may
also be adversely affected.
Metabolic syndrome, diabetes, mitochondrial disor-
ders, and cardiac myopathies can alter glycolytic/oxida-
tive metabolism and function of the heart. The reactivation
of carbohydrate-based metabolism in the adult is a
hallmark of pathologic changes in the heart that lead to
a functional degradation and heart failure. Our finding
that ERRg promotes this oxidative transition leads us to
speculate that this pathway may become compromisedCell Metabolism 6, 13–24, July 2007 ª2007 Elsevier Inc. 21
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ERRg in the treatment of cardiac hypertrophy and failure.
EXPERIMENTAL PROCEDURES
Animals
P0 or E18.5 c-sectioned mice were used for all studies. Congenic (F10)
ICR heterozygous crosses were used to generate all animals. Animal
studies complied with NIH guidelines for humane treatment of animals.
Protocols were approved by the Salk Institute for Biological Studies
Animal Care and Use Committee.
Histology and Electron Microscopy
Whole E18.5 hearts were formalin fixed and paraffin embedded.
Midventricle sections were stained with hematoxylin and eosin or
Masson’s trichrome. Hearts for electron microscopy were fixed in Kar-
novsky’s fixative, postfixed in 1% osmium tetroxide, and embedded in
plastic. Whole-mount X-gal staining was performed after light formal-
dehyde fixation (20 min on ice) and examined as is or by frozen section.
Electrocardiograms
Standard lead II ECG recording was adapted to neonatal (E18.5 to P0,
1.25 g) mice. Chlorided 0.004 inch sterling silver wires (Surepure
Chemetals) were sutured in a lead II arrangement (Dubin, 1994).
One-hundred second amplified ECGs were digitized at 6 kHz (National
Instruments), recorded with a custom MATLAB software application
(QRS), and stored for later analysis. The acquired ECG records were
analyzed with computer-aided semiautomatic wave analysis and
quantification of the ECG waveform. The analysis program was used
to group 100 individual beats based on identification of the time points
(at which the QRS complex crossed the isoelectric line of the ECG
recording) from which quantitative measurements were derived by
the software. All ECG recordings were made while mice were left
recumbent on a 37C water blanket. Core body temperatures were
recorded from a subset of animals.
Patch-Clamp Recordings
Single ventricular myocytes were isolated by enzymatic and mechan-
ical dissociation from E18.5 mice using standard conditions as previ-
ously described (Kondo et al., 2006; Brouillette et al., 2003). Cells
were maintained in MEM for 36 hr prior to studies performed at 21C ±
1C. Capacitance was not significantly altered in ERRg null cells,
indicating similar size.
Genomics
cRNA Preparation and Array Hybridization
Hearts from nine animals per genotype were collected and atria were
removed prior to storage at 20C (RNAlater, Ambion). Tissues were
then pooled into groups of three and processed for total RNA
(QIAGEN). Total RNA (10 mg) was reverse transcribed with the Super-
Script Choice system (Invitrogen). cDNA (1 mg) was in vitro transcribed
using the Enzo BioArray High Yield RNA system (Enzo Diagnostics).
cRNA (10 mg) was fragmented and hybridized to a MG 430 2.0 Gene-
Chip (Affymetrix) using standard procedures (45C, 16 hr). Washing
and staining were performed in a Fluidics Station 400 (Affymetrix) using
the protocol EukGE-WS2v4, and chips were scanned in an Affymetrix
GeneChip 2500 scanner.
Microarray Analysis
Data from three experiments per genotype were analyzed with Micro-
array Suite 5 software (Affymetrix) and the server-based online micro-
array analysis suite VAMPIRE (Hsiao et al., 2005). The ‘‘change’’ p
value threshold was <0.003. Fold change cutoff was 1.2. Genes whose
detection p value was >0.05 under all experimental conditions were
excluded from the analysis. Unbiased gene ontologies were assigned
to results within the VAMPIRE suite using the GOby tool. Classification
into genes encoding mitochondrial proteins was based on annotations
of the Affymetrix NetAffx Analysis Center, SOURCE, the National22 Cell Metabolism 6, 13–24, July 2007 ª2007 Elsevier Inc.Center for Biotechnology Information (PubMed), and the OXPHOS
and human_mitoDB_6_2002 lists curated at the Whitehead Institute
Center for Genome Research.
Chromatin Immunoprecipitation and ChIP-on-Chip
Experiments were performed as described previously (Dufour et al.,
2007). Approximately 1.8 g of tissue from a pool of 451 neonatal hearts
was used as the starting material for ChIP-on-chip experiments. A neo-
natal ERRg standard ChIP prepared using 0.5 g of starting material
was used for validating adult mouse cardiac ERRg target genes.
Quantitative RT-PCR
Molecular analysis of the channel composition of Esrrg/ hearts was
studied by qPCR. RNA from six animals of each genotype was col-
lected from E18.5 heart with RNeasy columns (QIAGEN). First-strand
cDNA was synthesized with 1 mg of purified RNA using SuperScript
II and random primers (Invitrogen). Samples were subsequently
treated with RNase H (Invitrogen). A 384-well microtiter dish format
was utilized for qPCR reactions with SYBR green (Sigma), and final re-
action volumes were 10 ml. High-throughput processing was achieved
using a semiautomated Beckman liquid handler, an ABI Prism 7900HT,
and sequence detection system software. For each biological sample,
qPCR reactions were performed in quadruplicate, and expression was
normalized to U36b4 expression. Bar graphs represent the averaged
relative expression of the six biological samples and the standard error
of the mean, assigning wild-type a relative expression of 1 for each
indicated transcript.
Respiratory Chain Assays
Myocardial ETC complex activities were assayed by standard
methods (Taylor and Turnbull, 1997). Ventricular myocardium from
individual hearts was weighed and homogenized in 0.5 ml 0.25 M
sucrose in a mini Potter-Elvehjem homogenizer. Protein was deter-
mined using a microplate Lowry assay (Bio-Rad). Citrate synthase
activity was determined photometrically (Shepherd and Garland,
1973). Complex I was measured as the rotenone-sensitive NADH:
CoQ1 oxidoreductase activity, and complex IV was measured as an
apparent first-order rate constant of cytochrome c oxidase activity
(Birch-Machin et al., 1994).
Blood Metabolites
Blood lactate and glucose were determined by collecting 1–5 ml of
whole blood from the tail tip. Blood glucose was measured with a One-
Touch Ultra glucometer (LifeScan), and lactate was measured with
a Lactate Scout (Sports Resource Group, Inc.).
DNA Isolation and Quantitation
Total DNA was prepared according to standard procedures and
digested with 100 mg/ml RNase A for 30 min at 37C. The relative copy
numbers of mitochondrial and nuclear genomes from 1 ng total DNA
were determined by real-time PCR with primers specific to mitochon-
drial Cytb (forward: 50-CCTTCATACCTCAAAGCAACGA-30; reverse:
50-GATAAGTAGGTTGGCTACTAGGATTCAGT-30) and nuclear Rn18s
(forward: 50-ACGGCCGGTACAGTGAAACT-30; reverse: 50-GAGCGAG
CGACCAAAGGA-30) genes. Serial dilutions of pooled DNA from E18.5
Esrrg+/+, Esrrg+/, and Esrrg/ (12 each) ventricular myocardia were
analyzed in parallel to establish a standard curve.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, one table, and two figures and can be
found with this article online at http://www.cellmetabolism.org/cgi/
content/full/6/1/13/DC1/.
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